177 related articles for article (PubMed ID: 33369742)
21. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
[TBL] [Abstract][Full Text] [Related]
22. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder.
Magro C; Crowson AN; Kovatich A; Burns F
Hum Pathol; 2002 Aug; 33(8):788-95. PubMed ID: 12203210
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
Toberer F; Hartschuh W; Hadaschik E
JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.
Rodríguez Pinilla SM; Roncador G; Rodríguez-Peralto JL; Mollejo M; García JF; Montes-Moreno S; Camacho FI; Ortiz P; Limeres-González MA; Torres A; Campo E; Navarro-Conde P; Piris MA
Am J Surg Pathol; 2009 Jan; 33(1):81-90. PubMed ID: 18987541
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD4
Takei I; Kawai K; Nakajima M; Ansai O; Anan T
J Dermatol; 2021 May; 48(5):e212-e214. PubMed ID: 33624292
[No Abstract] [Full Text] [Related]
29. Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases.
Leinweber B; Beltraminelli H; Kerl H; Cerroni L
Dermatology; 2009; 219(1):42-7. PubMed ID: 19349695
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous CD4
Jiang Y; Liu D; Alnasri A
Indian J Dermatol Venereol Leprol; 2020; 86(6):726-729. PubMed ID: 33063707
[No Abstract] [Full Text] [Related]
31. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Valentim FO; Oliveira CC; Miot HA
An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder: A clinical and histologic retrospective cohort study.
Stephan C; Grossman ME; Magro CM
Clin Dermatol; 2023; 41(6):666-679. PubMed ID: 37716580
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
Salah E
J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
35. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
[TBL] [Abstract][Full Text] [Related]
36. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
James E; Sokhn JG; Gibson JF; Carlson K; Subtil A; Girardi M; Wilson LD; Foss F
Leuk Lymphoma; 2015 Apr; 56(4):951-7. PubMed ID: 24996443
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
Plaza JA; Feldman AL; Magro C
J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
39. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
Bakr F; Wain EM; Wong S; Palmer R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
[TBL] [Abstract][Full Text] [Related]
40. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
